RIVASTIGMINE vs ROLAPITANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RIVASTIGMINE vs ROLAPITANT: Safety Overview
| Metric | RIVASTIGMINE | ROLAPITANT |
|---|---|---|
| Total FAERS Reports | 9,123 | 873 |
| Deaths Reported | 2,232 | 252 |
| Death Rate | 24.5% | 28.9% |
| Hospitalizations | 2,716 | 155 |
| Average Patient Age | 80.0 yrs | 61.4 yrs |
| % Female Patients | 59.5% | 57.5% |
| FDA Approval Date | Apr 21, 2000 | Oct 25, 2017 |
| Manufacturer | Novartis Pharmaceuticals Corporation | TerSera Therapeutics LLC |
| Route | TRANSDERMAL | ORAL |
| Marketing Status | Discontinued | Prescription |